Making the invisible visible: New method opens unexplored realms for liquid biopsies Michigan Medicine, Eureka Alert, May 3, 2019

Main|Search|PHGKB


Last Posted: May 03, 2019

---

• Making the invisible visible: New method opens unexplored realms for liquid biopsies
  Michigan Medicine, Eureka Alert, May 3, 2019
• IQN path ASBL report from the first European cfDNA consensus meeting: expert opinion on the minimal requirements for clinical ctDNA testing.
  Deans Zandra C et al. Virchows Archiv : an international journal of pathology 2019 Apr
• Journal of Translational Medicine advances in Translational Genomics and Genetics Era.
  Liu Wei et al. Journal of translational medicine 2019 Apr 17(1) 134
• Continuously capturing circulating cancer cells
  RP Kulkarni, Science Translational Medicine, April 24, 2019
• Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy.
  Zeng Chang et al. Cancer communications (London, England) 2019 Mar 39(1) 12
• Utility of cfDNA Fragmentation Patterns in Designing the Liquid Biopsy Profiling Panels to Improve Their Sensitivity.
  Ivanov Maxim et al. Frontiers in genetics 2019 10194
• Potential Utility of Liquid Biopsy as a Diagnostic and Prognostic Tool for the Assessment of Solid Tumors: Implications in the Precision Oncology.
  Mathai Roshni Ann et al. Journal of clinical medicine 2019 Mar 8(3)
• Breaking New Ground in Liquid Biopsy
  J Lemieux, GEN News, February 21, 2019
• Liquid biopsy and minimal residual disease - latest advances and implications for cure.
  Pantel Klaus, et al. Nature reviews. Clinical oncology 2019 2 0.
• Evolution of the genomic landscape of circulating tumor DNA (ctDNA) in metastatic prostate cancer over treatment and time.
  Hahn Andrew W et al. Cancer treatment and research communications 2019 Feb 19100120

more